Previously treated cases tested for RR-/MDR-TB (%) in Spain
Spain: Previously treated cases tested for RR-/MDR-TB was 94.0% in 2024. ◆ Volatile
Latest (2024)
94.0%
Change on year
up 34.3%
World rank
72nd
of 180 countries
All-time high
96.0%
in 2009
All-time low
13.0%
in 2006
Years of data
17
2006–2024
Previously treated cases tested for RR-/MDR-TB in Spain, 2006–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Spain stood at 94.0%.
Compared with earlier readings it is up 34.3% on the previous year and up 95.8% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Spain peaked at 96.0% in 2009 and was at its lowest, 13.0%, in 2006.
Spain ranks 72nd of 180 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Spain, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 13.0% | — |
| 2008 | 38.0% | +192.3% |
| 2009 | 96.0% | +152.6% |
| 2010 | 31.0% | -67.7% |
| 2011 | 25.0% | -19.4% |
| 2012 | 22.0% | -12.0% |
| 2013 | 35.0% | +59.1% |
| 2014 | 48.0% | +37.1% |
| 2015 | 37.0% | -22.9% |
| 2016 | 29.0% | -21.6% |
| 2017 | 23.0% | -20.7% |
| 2019 | 38.0% | +65.2% |
| 2020 | 52.0% | +36.8% |
| 2021 | 62.0% | +19.2% |
| 2022 | 82.0% | +32.3% |
| 2023 | 70.0% | -14.6% |
| 2024 | 94.0% | +34.3% |
Spain compared with similar countries
- Spain's 94.0% is above the median for high income countries, which is 83.0%, 1.1× the median. (57 countries reporting)
- Spain's 94.0% is above the median for Europe & Central Asia, which is 86.0%, 1.1× the median. (49 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 49.0% | 13.0% | 96.0% | 3 |
| 2010s | 32.0% | 22.0% | 48.0% | 9 |
| 2020s | 72.0% | 52.0% | 94.0% | 5 |
Countries ranked near Spain
More health data for Spain
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2629 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,290 deaths per 1,000 people (2090)
- Number of infants who die before age 1 108 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.0396 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0173 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0227 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Spain?
- Previously treated cases tested for rr-/mdr-tb in Spain was 94.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Spain?
- The highest recorded value was 96.0% in 2009.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Spain?
- The lowest recorded value was 13.0% in 2006.
- How does Spain rank for previously treated cases tested for rr-/mdr-tb?
- Spain ranks 72nd out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Spain?
- Over the last ten years it is up 95.8%. The long-run trend across the full record is volatile.
- Where does this Spain data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).